There was some information about this new drug, from the pharmaceutical company Abbott, that showed some promise, but I haven’t heard anything recently. The drug, called ABT-724, is similar to the ED drup apomorphine, which is sold in Europe as Uprima. However, Uprima hits a lot of dopamine receptors, including those that control nausea, so its use is limited. ABT-724, however, targets only one type of dopamine receptor, D4, which is involved in erection. So…it looked promising. Anyone heard about it? Let me know.